SCHEDULE 13G/A: Tocqueville Asset Management and Affiliates Disclose 4.4% Passive Stake in Champions Oncology

Sentiment:

Ownership Disclosure


Tocqueville Asset Management L.P., along with Taubenpost Capital L.P., Taubenpost Capital LLC, and Donald Wang, have disclosed a collective passive beneficial ownership of 4.4% in Champions Oncology, Inc. as of December 31, 2024.

Summary

  • Tocqueville Asset Management L.P., Taubenpost Capital L.P., Taubenpost Capital LLC, and Donald Wang collectively reported beneficial ownership of 608,915 shares of Champions Oncology, Inc. common stock.
  • This represents 4.4% of the total class of securities outstanding.
  • The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previous ownership disclosure.
  • The reporting persons share both voting and dispositive power over all 608,915 shares.
  • The ownership is stated to be for passive investment purposes, not for changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a routine Schedule 13G filing disclosing passive ownership, providing no operational or financial performance data to assess sentiment.

Management Comments

  • "The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11."
  • "Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."

Stakeholder Impact

  • Shareholders: Provides transparency regarding significant institutional ownership and the passive nature of the investment.
  • Advisory Clients of Tocqueville Asset Management L.P.: These clients are the direct beneficial owners of the reported securities.

Key Dates

DateDescription
12/31/2024Date of event requiring the filing of this statement, reflecting the ownership snapshot.
02/14/2025Date of filing of this Schedule 13G Amendment No. 1.

Keywords

Champions Oncology, Tocqueville Asset Management, Taubenpost Capital, Donald Wang, Schedule 13G, Beneficial Ownership, Passive Investment, Common Stock, SEC Filing, Institutional Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.